X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
male (18) 18
female (17) 17
aged (16) 16
middle aged (15) 15
index medicus (13) 13
hematology (12) 12
adult (11) 11
aged, 80 and over (8) 8
treatment outcome (7) 7
oncology (6) 6
prospective studies (6) 6
therapy (6) 6
antineoplastic agents - therapeutic use (5) 5
care and treatment (5) 5
diagnosis (5) 5
disease-free survival (5) 5
abridged index medicus (4) 4
analysis (4) 4
follow-up studies (4) 4
hemic and lymphatic diseases (4) 4
management (4) 4
chemotherapy (3) 3
chronic myeloid leukemia (3) 3
clinical medicine (3) 3
doxorubicin - analogs & derivatives (3) 3
imatinib (3) 3
klinisk medicin (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
mycosis fungoides (3) 3
mycosis fungoides - drug therapy (3) 3
prognosis (3) 3
remission induction (3) 3
risk factors (3) 3
survival rate (3) 3
young adult (3) 3
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
center doctors organization (2) 2
chi-square distribution (2) 2
clinical trials (2) 2
combination (2) 2
combined modality therapy (2) 2
cyclophosphamide (2) 2
dasatinib (2) 2
dexamethasone - administration & dosage (2) 2
doxorubicin - administration & dosage (2) 2
doxorubicin - adverse effects (2) 2
doxorubicin - therapeutic use (2) 2
efficacy (2) 2
europe - epidemiology (2) 2
experience (2) 2
factor viii - immunology (2) 2
factor viii - therapeutic use (2) 2
factor-viii inhibitors (2) 2
hematologi (2) 2
hematology, oncology and palliative medicine (2) 2
hemophilia a - drug therapy (2) 2
hemophilia a - mortality (2) 2
hemorrhage - mortality (2) 2
italy (2) 2
kaplan-meier estimate (2) 2
leukemia (2) 2
multiple myeloma - drug therapy (2) 2
mutation (2) 2
nilotinib (2) 2
pegylated liposomal doxorubicin (2) 2
photochemotherapy (2) 2
polyethylene glycols - adverse effects (2) 2
polyethylene glycols - therapeutic use (2) 2
puva (2) 2
recurrence (2) 2
registries - statistics & numerical data (2) 2
research paper (2) 2
risk assessment (2) 2
settore med/15 - malattie del sangue (2) 2
survival analysis (2) 2
t-cell lymphoma (2) 2
trial (2) 2
tyrosine kinase inhibitor (2) 2
united-kingdom (2) 2
1st complete remission (1) 1
abc transporters (1) 1
abc transporters; abcb1; early molecular response; hoct1; nilotinib; oncology (1) 1
abcb1 (1) 1
abcg2 (1) 1
acquired hemophilia (1) 1
acute lymphoblastic leukemia (1) 1
acute lymphocytic-leukemia (1) 1
acute myeloid leukemia (1) 1
adolescent (1) 1
age (1) 1
age factors (1) 1
aged patients (1) 1
agnogenic myeloid metaplasia (1) 1
aminoglycosides - administration & dosage (1) 1
aminoglycosides - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2610 - 2610
Abstract Background: Splanchnic venous thrombosis (SVT) encompasses thrombosis in the mesenteric, splenic or portal veins (with or without hepatic veins... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4257 - 4257
Abstract This study retrospectively evaluated 144 consecutive patients with unusual site thrombosis who referred to our Thrombosis Center between 2000 and... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4976 - 4976
Abstract AML patients early relapsing within 12 months, still represents an extremely poor prognosis setting. Cytogenetic and molecular data are not diagnostic... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5109 - 5109
Abstract BACKGROUND The incidence of non Hodgkin's lymphoma (NHL) increases with age, over one third of NHL cases involves elderly patients >70 years of age.... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3943 - 3943
Abstract In elderly AML the prognosis still remains poor and unchanged in the last decades, with only 10% long term OS. Aging is often synonymous of frailty,... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1806 - 1806
Abstract The management of patients with chronic myeloid leukemia (CML) during pregnancy is a matter of continuous debate. The introduction of the tyrosin... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5433 - 5433
Abstract Anthracyclines (AC) still constitute the mainstay of the 1st line treatment in lymphoma: their use, however, is limited by the occurrence of Cardiac... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 1735 - 1735
Abstract Abstract 1735 Background: Essential Thrombocytemia (ET) is a myeloproliferative neoplasm characterized by increased risk of vascular events.... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 22 - 33
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3621 - 3621
Abstract Abstract 3621 Acute myeloid leukemia (AML) has a dismal prognosis in elderly population because of intrinsic chemoresistance and frailty of patients.... 
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 3072 - 3072
Abstract Abstract 3072 Thromboembolic disease (TE) is a major cause of morbidity and mortality in Essential Thrombocythemia (ET). Recently JAK2V617 mutational... 
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 3953 - 3953
Abstract Abstract 3953 Oral bexarotene, a novel retinoid that selectively activates retinoid × receptors, is approved for the treatment of cutaneous... 
Journal Article
Cancer, ISSN 0008-543X, 05/2018, Volume 124, Issue 10, pp. 2228 - 2237
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3021 - 3021
Abstract Introduction: Bosutinib is a Src/Abl tyrosine kinase inhibitor (TKI) currently licensed for patients with Ph+ chronic-phase (CP), accelerated-phase... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 44 - 44
Abstract Background. Many prognostic scores have been proposed for risk stratification of chronic myeloid leukemia (CML) patients: the Sokal is the oldest and... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 458 - 458
Abstract BACKGROUND: In chronic phase (CP) chronic myeloid leukemia (CML) nilotinib showed better efficacy compared to imatinib. The higher rates of deep... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.